Cytotoxic T-Lymphocyte-Associated Antigen-4SALAMA, April K. S; HODI, F. Stephen.Clinical cancer research (Print). 2011, Vol 17, Num 14, pp 4622-4628, issn 1078-0432, 7 p.Article

Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimenMOCHIZUKI, Kazuo; SATO, Yuji; TODO, Satoru et al.International journal of oncology. 2004, Vol 25, Num 1, pp 121-131, issn 1019-6439, 11 p.Article

Melan-A―specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4KLEIN, Oliver; EBERT, Lisa M; LUESCHER, Immanuel F et al.Clinical cancer research (Print). 2009, Vol 15, Num 7, pp 2507-2513, issn 1078-0432, 7 p.Article

Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der TumorimmuntherapieJÄGER, D.Arzneimittel-Forschung. 2012, Vol 62, issn 0004-4172, S9-S10, SUP1Conference Paper

Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytesBENDLE, Gavin M; HOLLER, Angelika; PANG, Luke-Kwok et al.Cancer research (Baltimore). 2004, Vol 64, Num 21, pp 8052-8056, issn 0008-5472, 5 p.Article

Cytotoxic T-lymphocyte-associated antigen-4HODI, F. Stephen.Clinical cancer research. 2007, Vol 13, Num 18, pp 5238-5242, issn 1078-0432, 5 p., 1Article

MUC4-specific CTLsMADSEN, Caroline B; JESS, Per; HARNDAHL, Mikkel et al.Immunopharmacology and immunotoxicology. 2013, Vol 35, Num 1-6, pp 203-204, issn 0892-3973, 2 p.Article

X-Irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditionsISHIKAWA, Eiichi; TSUBOI, Koji; SAIJO, Kaoru et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 5, pp 1505-1512, issn 0360-3016, 8 p.Article

Clinical Development of the Anti-CTLA-4 Antibody Tremelimumab : Immunologic checkpoints for cancer treatment: from scientific rationale to clinical applicationRIBAS, Antoni.Seminars in oncology. 2010, Vol 37, Num 5, pp 450-454, issn 0093-7754, 5 p.Article

Antigen bias in T cell cross-primingWOLKERS, Monika C; BROUWENSTIJN, Nathalie; BAKKER, Arnold H et al.Science (Washington, D.C.). 2004, Vol 304, Num 5675, pp 1314-1317, issn 0036-8075, 4 p.Article

Cytotoxic T cellsANDERSEN, Mads Hald; SCHRAMA, David; THOR STRATEN, Per et al.Journal of investigative dermatology. 2005, Vol 126, Num 1, pp 32-41, issn 0022-202X, 10 p.Article

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8⁺ T cells in vivoJACKAMAN, Connie; MAJEWSKI, David; FOX, Simon A et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 12, pp 2343-2356, issn 0340-7004, 14 p.Article

License to kill: Formulation requirements for optimal priming of CD8⁺ CTL responses with particulate vaccine delivery systemsFOGED, Camilla; HANSEN, Jon; MARIE AGGER, Else et al.European journal of pharmaceutical sciences. 2012, Vol 45, Num 4, pp 482-491, issn 0928-0987, 10 p.Conference Paper

Orphan granzymes find a homeBOVENSCHEN, Niels; KUMMER, J. Alain.Immunological reviews. 2010, Vol 235, pp 117-127, issn 0105-2896, 11 p.Article

Effect of Frequently Used Chemotherapeutic Drugs on Cytotoxic Activity of Human Cytotoxic T-lymphocytesMARKASZ, Laszlo; SKRIBEK, Henriette; UHLIN, Michael et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 3, pp 283-293, issn 1524-9557, 11 p.Article

Gender-limited association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) polymorphism with cord blood IgE levelsCHANG, Jen-Chieh; LIU, Chieh-An; HAU CHUANG et al.Pediatric allergy and immunology. 2004, Vol 15, Num 6, pp 506-512, issn 0905-6157, 7 p.Article

Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicityYAMADA, S; SHINOZAKI, K; AGEMATSU, K et al.Clinical and experimental immunology (Print). 2002, Vol 130, Num 3, pp 424-430, issn 0009-9104, 7 p.Article

Identification of novel HLA-A^*0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8SHUFA LI; HAIYING LI; BING CHEN et al.Vaccine. 2013, Vol 31, Num 12, pp 1610-1615, issn 0264-410X, 6 p.Article

Dynamics of haplotype frequency change in a CD8+T_L epitope of simian immunodeficiency virusHUGHES, Austin L; O'CONNOR, Shelby; DUDLEY, Dawn M et al.Infection, genetics and evolution (Print). 2010, Vol 10, Num 4, pp 555-560, issn 1567-1348, 6 p.Article

CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosisYOUSEFIPOUR, G; ERFANI, N; MOMTAHAN, M et al.Acta neurologica scandinavica. 2009, Vol 120, Num 6, pp 424-429, issn 0001-6314, 6 p.Article

The clinical utility of inhibiting CD28-mediated costimulationLINSLEY, Peter S; NADLER, Steven G.Immunological reviews. 2009, Vol 229, pp 307-321, issn 0105-2896, 15 p.Article

Expression of human cytotoxic T-lymphocyte antigen 4 (hCTLA4) fused with Hepatitis B surface antigen (HBsAg) using Pichia pastorisLEE, Kyoung-Hoon; HONG, Hye-Jin; LIM, Sang-Min et al.Enzyme and microbial technology. 2006, Vol 39, Num 3, pp 481-485, issn 0141-0229, 5 p.Conference Paper

Clinical course and immune response of a renal cell carcinoma patient to adoptive transfer of autologous cytotoxic T lymphocytesKAWAI, K; SAIJO, K; OIKAWA, T et al.Clinical and experimental immunology (Print). 2003, Vol 134, Num 2, pp 264-269, issn 0009-9104, 6 p.Article

Generation and evaluation of the efficacy of rhesus monkey soluble cytotoxic T lymphocyte-associated antigen-4 in the allogeneic mixed lymphocyte reactionKIM, Jung-Sik; CHOI, Inho; PARK, Chung-Gyu et al.Biotechnology letters. 2012, Vol 34, Num 12, pp 2191-2197, issn 0141-5492, 7 p.Article

The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptidesZHANG, Xiu-Min; ZHANG, Yun-Fei; HU, Pei-Zhen et al.Oncology reports. 2008, Vol 20, Num 1, pp 245-252, issn 1021-335X, 8 p.Article